Blood Based Biomarker Market Early Diagnosis of Cancer is Facilitating Growth
The blood based biomarker market is estimated to be valued at US$ 18.8 billion in 2022 and is expected to exhibit a CAGR of 12.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Blood based biomarkers are biological molecules found in blood that are indicators of … Read more